The central hypotensive effect induced by α2-adrenergic receptor stimulation is dependent on endothelial nitric oxide synthase

Journal of Hypertension

Volumn 26, Issue 5, 2008, Pages 1033-1036

  Feldman, Josiane ^a   Fellmann, Lyne ^a   Bousquet, Pascal ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Lab d'Ethologie et de Neurobiologie   (France)

Author keywords

Antihypertensive drugs; Centrally acting drugs; Dexmedetomidine; Endothelial nitric oxide synthase; Knockout mice; 2 adrenergic agonists

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

AGONIST; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; HYPOTENSION; INTRINSIC SYMPATHOMIMETIC ACTIVITY; KNOCKOUT MOUSE; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

EID: 42049091232     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f7cbab     Document Type: Article

References (21)

1. Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res 2007; 1134:27-32.
2. Ishide T, Preuss CV, Maher TJ, Ally A. Neurochemistry within ventrolateral medulla and cardiovascular effects during static exercise following eNOS antagonism. Neurosci Res 2005; 52:21-30.
3. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 1999; 43:639-649.
4. Kishi T, Hirooka Y, Kimura Y, Sakai K, Ito K, Shimokawa H, Takeshita A. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP: rostral ventrolateral medulla: stroke-prone spontaneously hypertensive rats. Hypertension 2003; 41:255-260.
5. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38:896-901.
6. Sy GY, Bruban V, Bousquet P, Feldman J. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines. Hypertension 2001; 37:246-249.
7. Sy GY, Bruban V, Bousquet P, Feldman J. Nitric oxide discriminates the sites and mechanisms of action of centrally acting antihypertensive drugs in rabbits. Neuropharmacology 2002; 43:1330-1338.
8. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007; 41:245-252.
9. Jeon YT, Luo C, Fooray C, Vaysse PJ-J, Branchek TA, Gluchowski C. Pharmacological evaluation of UK-14,304 analogs at cloned human alpha-adrenergic receptors. Bioorg Med Chem Lett 1995; 5:2255-2258.
10. Sy GY, Urosevic D, Fellmann L, Greney H, Bousquet P, Feldman J. GIRK channels are involved in the hypotensive effect of I1 imidazoline receptor selective ligands. J Hypertens 2007 (in press).
11. Zandberg P, De Jong W, De Wied D. Effect of catecholamine-receptor stimulating agents on blood pressure after local application in the nucleus tractus solitarii of the medulla oblongata. Eur J Pharmacol 1979; 55:43-56.
12. Chan RK, Sawchenko PE. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry. J Neurosci 1998; 18:371-387.
13. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
14. Sun MK. Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation. Pharmacol Rev 1996; 48:465-494.
15. Ortiz PA, Garvin JL. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 2003; 284:R628-R638.
16. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93:13176-13181.
17. Jasper JR, Lesnick JD, Chang LK, Yamanishi SS, Chang TK, Hsu SA, et al. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol 1998; 55:1035-1043.
18. Ishikawa S, Kugawa S, Neya K, Suzuki Y, Kawasaki A, Hayama T, Ueda K. Hemodynamic effects of dexmedetomidine in patients after cardiac surgery. Minerva Chir 2006; 61:215-219.
19. Sy GY, Bousquet P, Feldman J. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits. Auton Neurosci 2006; 128 (1-2):19-24.
20. Lindauer U, Dreier J, Angstwurm K, Rubin I, Villringer A, Einhaupl KM, Dirnagl U. Role of nitric oxide synthase inhibition in leukocyte-endothelium interaction in the rat pial microvasculature. J Cereb Blood Flow Metab 1996; 16:1143-1152.
21. Phillipson M, Henriksnas J, Holstad M, Sandler S, Holm L. Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice. Am J Physiol Gastrointest Liver Physiol 2003; 285:G154-G162.